1 Study Coverage
    1.1 Interventional X-ray Contrast and Imaging Agents Product Introduction
    1.2 Market by Type
        1.2.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Iodinated Contrast Media
        1.2.3 Barium-Based Contrast Media
        1.2.4 Microbubble Contrast Media
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Heart Disease
        1.3.3 Neurological
        1.3.4 Urology
        1.3.5 General Surgery
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Interventional X-ray Contrast and Imaging Agents Sales Estimates and Forecasts 2017-2028
    2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Estimates and Forecasts 2017-2028
    2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Interventional X-ray Contrast and Imaging Agents Sales by Region
        2.4.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2017-2022)
        2.4.2 Global Sales Interventional X-ray Contrast and Imaging Agents by Region (2023-2028)
    2.5 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region
        2.5.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2017-2022)
        2.5.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers
        3.1.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Sales (2017-2022)
        3.1.2 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Interventional X-ray Contrast and Imaging Agents in 2021
    3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers
        3.2.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2017-2022)
        3.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Interventional X-ray Contrast and Imaging Agents Revenue in 2021
    3.3 Global Interventional X-ray Contrast and Imaging Agents Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Interventional X-ray Contrast and Imaging Agents Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Type
        4.1.1 Global Interventional X-ray Contrast and Imaging Agents Historical Sales by Type (2017-2022)
        4.1.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Sales by Type (2023-2028)
        4.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2017-2028)
    4.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type
        4.2.1 Global Interventional X-ray Contrast and Imaging Agents Historical Revenue by Type (2017-2022)
        4.2.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2017-2028)
    4.3 Global Interventional X-ray Contrast and Imaging Agents Price by Type
        4.3.1 Global Interventional X-ray Contrast and Imaging Agents Price by Type (2017-2022)
        4.3.2 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Application
        5.1.1 Global Interventional X-ray Contrast and Imaging Agents Historical Sales by Application (2017-2022)
        5.1.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Sales by Application (2023-2028)
        5.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2017-2028)
    5.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Application
        5.2.1 Global Interventional X-ray Contrast and Imaging Agents Historical Revenue by Application (2017-2022)
        5.2.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2017-2028)
    5.3 Global Interventional X-ray Contrast and Imaging Agents Price by Application
        5.3.1 Global Interventional X-ray Contrast and Imaging Agents Price by Application (2017-2022)
        5.3.2 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Interventional X-ray Contrast and Imaging Agents Market Size by Type
        6.1.1 North America Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2028)
        6.1.2 North America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2028)
    6.2 North America Interventional X-ray Contrast and Imaging Agents Market Size by Application
        6.2.1 North America Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2028)
        6.2.2 North America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2028)
    6.3 North America Interventional X-ray Contrast and Imaging Agents Market Size by Country
        6.3.1 North America Interventional X-ray Contrast and Imaging Agents Sales by Country (2017-2028)
        6.3.2 North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Type
        7.1.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2028)
        7.1.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2028)
    7.2 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Application
        7.2.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2028)
        7.2.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2028)
    7.3 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Country
        7.3.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2017-2028)
        7.3.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Size by Type
        8.1.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2028)
        8.1.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2028)
    8.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Size by Application
        8.2.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2028)
        8.2.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2028)
    8.3 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Size by Region
        8.3.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Region (2017-2028)
        8.3.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Type
        9.1.1 Latin America Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2028)
        9.1.2 Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2028)
    9.2 Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Application
        9.2.1 Latin America Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2028)
        9.2.2 Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2028)
    9.3 Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Country
        9.3.1 Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2017-2028)
        9.3.2 Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Size by Type
        10.1.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2028)
    10.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Size by Application
        10.2.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2028)
    10.3 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Size by Country
        10.3.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bracco
        11.1.1 Bracco Corporation Information
        11.1.2 Bracco Overview
        11.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bracco Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bracco Recent Developments
    11.2 General Electric
        11.2.1 General Electric Corporation Information
        11.2.2 General Electric Overview
        11.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 General Electric Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 General Electric Recent Developments
    11.3 Guerbet
        11.3.1 Guerbet Corporation Information
        11.3.2 Guerbet Overview
        11.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Guerbet Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Guerbet Recent Developments
    11.4 Fujifilm Visualsonics
        11.4.1 Fujifilm Visualsonics Corporation Information
        11.4.2 Fujifilm Visualsonics Overview
        11.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Fujifilm Visualsonics Recent Developments
    11.5 Imax
        11.5.1 Imax Corporation Information
        11.5.2 Imax Overview
        11.5.3 Imax Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Imax Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Imax Recent Developments
    11.6 J.B. Chemicals & Pharmaceuticals
        11.6.1 J.B. Chemicals & Pharmaceuticals Corporation Information
        11.6.2 J.B. Chemicals & Pharmaceuticals Overview
        11.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 J.B. Chemicals & Pharmaceuticals Recent Developments
    11.7 Jodas Expoim
        11.7.1 Jodas Expoim Corporation Information
        11.7.2 Jodas Expoim Overview
        11.7.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Jodas Expoim Recent Developments
    11.8 Lantheus Medical Imaging
        11.8.1 Lantheus Medical Imaging Corporation Information
        11.8.2 Lantheus Medical Imaging Overview
        11.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Lantheus Medical Imaging Recent Developments
    11.9 Nano Therapeutics
        11.9.1 Nano Therapeutics Corporation Information
        11.9.2 Nano Therapeutics Overview
        11.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Nano Therapeutics Recent Developments
    11.10 Novalek Pharmaceuticals
        11.10.1 Novalek Pharmaceuticals Corporation Information
        11.10.2 Novalek Pharmaceuticals Overview
        11.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Novalek Pharmaceuticals Recent Developments
    11.11 Taejoon Pharm
        11.11.1 Taejoon Pharm Corporation Information
        11.11.2 Taejoon Pharm Overview
        11.11.3 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Taejoon Pharm Recent Developments
    11.12 Unijules Life Sciences
        11.12.1 Unijules Life Sciences Corporation Information
        11.12.2 Unijules Life Sciences Overview
        11.12.3 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Unijules Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Interventional X-ray Contrast and Imaging Agents Industry Chain Analysis
    12.2 Interventional X-ray Contrast and Imaging Agents Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Interventional X-ray Contrast and Imaging Agents Production Mode & Process
    12.4 Interventional X-ray Contrast and Imaging Agents Sales and Marketing
        12.4.1 Interventional X-ray Contrast and Imaging Agents Sales Channels
        12.4.2 Interventional X-ray Contrast and Imaging Agents Distributors
    12.5 Interventional X-ray Contrast and Imaging Agents Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Interventional X-ray Contrast and Imaging Agents Industry Trends
    13.2 Interventional X-ray Contrast and Imaging Agents Market Drivers
    13.3 Interventional X-ray Contrast and Imaging Agents Market Challenges
    13.4 Interventional X-ray Contrast and Imaging Agents Market Restraints
14 Key Findings in The Global Interventional X-ray Contrast and Imaging Agents Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Iodinated Contrast Media
    Table 3. Major Manufacturers of Barium-Based Contrast Media
    Table 4. Major Manufacturers of Microbubble Contrast Media
    Table 5. Major Manufacturers of Other
    Table 6. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2017-2022) & (K MT)
    Table 9. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2017-2022)
    Table 10. Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2023-2028) & (K MT)
    Table 11. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2023-2028)
    Table 12. Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2017-2022)
    Table 14. Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2023-2028)
    Table 16. Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers (2017-2022) & (K MT)
    Table 17. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Manufacturers (2017-2022)
    Table 18. Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Manufacturers (2017-2022)
    Table 20. Interventional X-ray Contrast and Imaging Agents Price by Manufacturers (2017-2022) &(USD/MT)
    Table 21. Global Interventional X-ray Contrast and Imaging Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Interventional X-ray Contrast and Imaging Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional X-ray Contrast and Imaging Agents as of 2021)
    Table 23. Interventional X-ray Contrast and Imaging Agents Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Interventional X-ray Contrast and Imaging Agents Product Offered
    Table 25. Date of Manufacturers Enter into Interventional X-ray Contrast and Imaging Agents Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2022) & (K MT)
    Table 28. Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2023-2028) & (K MT)
    Table 29. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Type (2017-2022)
    Table 30. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Type (2023-2028)
    Table 31. Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Type (2017-2022)
    Table 34. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Type (2023-2028)
    Table 35. Interventional X-ray Contrast and Imaging Agents Price by Type (2017-2022) & (USD/MT)
    Table 36. Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Type (2023-2028) & (USD/MT)
    Table 37. Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2022) & (K MT)
    Table 38. Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2023-2028) & (K MT)
    Table 39. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Application (2017-2022)
    Table 40. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Application (2023-2028)
    Table 41. Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Application (2017-2022)
    Table 44. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Application (2023-2028)
    Table 45. Interventional X-ray Contrast and Imaging Agents Price by Application (2017-2022) & (USD/MT)
    Table 46. Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Application (2023-2028) & (USD/MT)
    Table 47. North America Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2022) & (K MT)
    Table 48. North America Interventional X-ray Contrast and Imaging Agents Sales by Type (2023-2028) & (K MT)
    Table 49. North America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2022) & (K MT)
    Table 52. North America Interventional X-ray Contrast and Imaging Agents Sales by Application (2023-2028) & (K MT)
    Table 53. North America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Interventional X-ray Contrast and Imaging Agents Sales by Country (2017-2022) & (K MT)
    Table 56. North America Interventional X-ray Contrast and Imaging Agents Sales by Country (2023-2028) & (K MT)
    Table 57. North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2022) & (K MT)
    Table 60. Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2023-2028) & (K MT)
    Table 61. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2022) & (K MT)
    Table 64. Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2023-2028) & (K MT)
    Table 65. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2017-2022) & (K MT)
    Table 68. Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2023-2028) & (K MT)
    Table 69. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2022) & (K MT)
    Table 72. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Type (2023-2028) & (K MT)
    Table 73. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2022) & (K MT)
    Table 76. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Application (2023-2028) & (K MT)
    Table 77. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Region (2017-2022) & (K MT)
    Table 80. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Region (2023-2028) & (K MT)
    Table 81. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2022) & (K MT)
    Table 84. Latin America Interventional X-ray Contrast and Imaging Agents Sales by Type (2023-2028) & (K MT)
    Table 85. Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2022) & (K MT)
    Table 88. Latin America Interventional X-ray Contrast and Imaging Agents Sales by Application (2023-2028) & (K MT)
    Table 89. Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2017-2022) & (K MT)
    Table 92. Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2023-2028) & (K MT)
    Table 93. Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Type (2017-2022) & (K MT)
    Table 96. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Type (2023-2028) & (K MT)
    Table 97. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Application (2017-2022) & (K MT)
    Table 100. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Application (2023-2028) & (K MT)
    Table 101. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Country (2017-2022) & (K MT)
    Table 104. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Country (2023-2028) & (K MT)
    Table 105. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Bracco Corporation Information
    Table 108. Bracco Description and Major Businesses
    Table 109. Bracco Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Bracco Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Bracco Recent Developments
    Table 112. General Electric Corporation Information
    Table 113. General Electric Description and Major Businesses
    Table 114. General Electric Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. General Electric Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. General Electric Recent Developments
    Table 117. Guerbet Corporation Information
    Table 118. Guerbet Description and Major Businesses
    Table 119. Guerbet Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. Guerbet Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Guerbet Recent Developments
    Table 122. Fujifilm Visualsonics Corporation Information
    Table 123. Fujifilm Visualsonics Description and Major Businesses
    Table 124. Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Fujifilm Visualsonics Recent Developments
    Table 127. Imax Corporation Information
    Table 128. Imax Description and Major Businesses
    Table 129. Imax Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 130. Imax Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Imax Recent Developments
    Table 132. J.B. Chemicals & Pharmaceuticals Corporation Information
    Table 133. J.B. Chemicals & Pharmaceuticals Description and Major Businesses
    Table 134. J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. J.B. Chemicals & Pharmaceuticals Recent Developments
    Table 137. Jodas Expoim Corporation Information
    Table 138. Jodas Expoim Description and Major Businesses
    Table 139. Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 140. Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Jodas Expoim Recent Developments
    Table 142. Lantheus Medical Imaging Corporation Information
    Table 143. Lantheus Medical Imaging Description and Major Businesses
    Table 144. Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 145. Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Lantheus Medical Imaging Recent Developments
    Table 147. Nano Therapeutics Corporation Information
    Table 148. Nano Therapeutics Description and Major Businesses
    Table 149. Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 150. Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Nano Therapeutics Recent Developments
    Table 152. Novalek Pharmaceuticals Corporation Information
    Table 153. Novalek Pharmaceuticals Description and Major Businesses
    Table 154. Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 155. Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Novalek Pharmaceuticals Recent Developments
    Table 157. Taejoon Pharm Corporation Information
    Table 158. Taejoon Pharm Description and Major Businesses
    Table 159. Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 160. Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Taejoon Pharm Recent Developments
    Table 162. Unijules Life Sciences Corporation Information
    Table 163. Unijules Life Sciences Description and Major Businesses
    Table 164. Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 165. Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Unijules Life Sciences Recent Developments
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Interventional X-ray Contrast and Imaging Agents Distributors List
    Table 170. Interventional X-ray Contrast and Imaging Agents Customers List
    Table 171. Interventional X-ray Contrast and Imaging Agents Market Trends
    Table 172. Interventional X-ray Contrast and Imaging Agents Market Drivers
    Table 173. Interventional X-ray Contrast and Imaging Agents Market Challenges
    Table 174. Interventional X-ray Contrast and Imaging Agents Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Interventional X-ray Contrast and Imaging Agents Product Picture
    Figure 3. Global Interventional X-ray Contrast and Imaging Agents Market Share by Type in 2021 & 2028
    Figure 3. Iodinated Contrast Media Product Picture
    Figure 4. Barium-Based Contrast Media Product Picture
    Figure 5. Microbubble Contrast Media Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Interventional X-ray Contrast and Imaging Agents Market Share by Application in 2021 & 2028
    Figure 8. Heart Disease
    Figure 9. Neurological
    Figure 10. Urology
    Figure 11. General Surgery
    Figure 12. Other
    Figure 13. Interventional X-ray Contrast and Imaging Agents Report Years Considered
    Figure 14. Global Interventional X-ray Contrast and Imaging Agents Sales 2017-2028 (K MT)
    Figure 15. Global Interventional X-ray Contrast and Imaging Agents Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Interventional X-ray Contrast and Imaging Agents Revenue 2017-2028 (US$ Million)
    Figure 17. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2017-2022)
    Figure 19. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2023-2028)
    Figure 20. North America Interventional X-ray Contrast and Imaging Agents Sales YoY (2017-2028) & (K MT)
    Figure 21. North America Interventional X-ray Contrast and Imaging Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Interventional X-ray Contrast and Imaging Agents Sales YoY (2017-2028) & (K MT)
    Figure 23. Europe Interventional X-ray Contrast and Imaging Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Sales YoY (2017-2028) & (K MT)
    Figure 25. Asia-Pacific Interventional X-ray Contrast and Imaging Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Interventional X-ray Contrast and Imaging Agents Sales YoY (2017-2028) & (K MT)
    Figure 27. Latin America Interventional X-ray Contrast and Imaging Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Sales YoY (2017-2028) & (K MT)
    Figure 29. Middle East & Africa Interventional X-ray Contrast and Imaging Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Interventional X-ray Contrast and Imaging Agents Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Interventional X-ray Contrast and Imaging Agents in the World: Market Share by Interventional X-ray Contrast and Imaging Agents Revenue in 2021
    Figure 32. Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2017-2028)
    Figure 34. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2017-2028)
    Figure 35. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2017-2028)
    Figure 36. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2017-2028)
    Figure 37. North America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2017-2028)
    Figure 38. North America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2017-2028)
    Figure 39. North America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2017-2028)
    Figure 40. North America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2017-2028)
    Figure 41. North America Interventional X-ray Contrast and Imaging Agents Sales Share by Country (2017-2028)
    Figure 42. North America Interventional X-ray Contrast and Imaging Agents Revenue Share by Country (2017-2028)
    Figure 43. U.S. Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2017-2028)
    Figure 46. Europe Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2017-2028)
    Figure 48. Europe Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Interventional X-ray Contrast and Imaging Agents Sales Share by Country (2017-2028)
    Figure 50. Europe Interventional X-ray Contrast and Imaging Agents Revenue Share by Country (2017-2028)
    Figure 51. Germany Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 52. France Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue Share by Region (2017-2028)
    Figure 62. China Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 65. India Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Interventional X-ray Contrast and Imaging Agents Sales Share by Country (2017-2028)
    Figure 77. Latin America Interventional X-ray Contrast and Imaging Agents Revenue Share by Country (2017-2028)
    Figure 78. Mexico Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue Share by Country (2017-2028)
    Figure 87. Turkey Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Interventional X-ray Contrast and Imaging Agents Revenue (2017-2028) & (US$ Million)
    Figure 90. Interventional X-ray Contrast and Imaging Agents Value Chain
    Figure 91. Interventional X-ray Contrast and Imaging Agents Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed